BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AQUA07 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of AQUA07\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07617337-2353@assetmemo.bio
DTSTAMP:20261121T005823Z
DTSTART;VALUE=DATE:20300831
DTEND;VALUE=DATE:20300901
SUMMARY:AQUA07: Phase 1 readout est. (NCT07617337)
DESCRIPTION:AQUA07\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: AQUA07 i
 n Patients With ALK-Positive Non-Small Cell Lung Cancer\nEstimated primary
  completion: 31 August 2030. This is a ClinicalTrials.gov estimate\, not a
  confirmed readout date\, and it can move.\nDrug page: https://assetmemo.b
 io/drug/aqua07#upcoming-events\nRegistry record: https://clinicaltrials.go
 v/study/NCT07617337
URL:https://assetmemo.bio/drug/aqua07#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
